| Everolimus studied in …STUDIED_INderived200 of 518show all (up to 200) |
|---|
| → studied in | NCT05188118early Phase 1 · completed Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · 518 trials list this drug (71 active) | — | — | Digestive System Neuroendocrine Tumor G1,Digestive System Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03950609Phase 2 · active not recruiting Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors · 518 trials list this drug (71 active) | — | — | Digestive System Neuroendocrine Neoplasm,Neuroendocrine Neoplasm,Multiple Endocrine Neoplasia Type 1+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665739Phase 2 · recruiting Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Functioning Lung Neuroendocrine Tumor,Lung Neuroendocrine Neoplasm,Non-Functioning Lung Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252585Phase 4 · active not recruiting A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) · 518 trials list this drug (71 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05508906Phase 1 · active not recruiting Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012371Phase 2 · active not recruiting Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer · 518 trials list this drug (71 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · 518 trials list this drug (71 active) | — | — | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia,FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma,FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943755Phase 2/Phase 3 · recruiting Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802759Phase 1/Phase 2 · recruiting A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01582191Phase 1 · completed Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428396Phase 2 · active not recruiting Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06382948Phase 3 · recruiting Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02962414Phase 3 · active not recruiting Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740334Phase 1 · active not recruiting Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL · 518 trials list this drug (71 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06105632Phase 2 · active not recruiting A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04485559Phase 1 · recruiting Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) · 518 trials list this drug (71 active) | — | — | Glioma,Low Grade Glioma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167530Phase 1 · completed Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer · 518 trials list this drug (71 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476939Phase 3 · recruiting Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 · 518 trials list this drug (71 active) | — | — | Diffuse Intrinsic Pontine Glioma,Diffuse Midline Glioma,Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936858Phase 2 · completed RAD001 for Patients With Radioiodine Refractory Thyroid Cancer · 518 trials list this drug (71 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 518 trials list this drug (71 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680921Phase 3 · active not recruiting A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE) · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07426484Phase 4 · recruiting Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy · 518 trials list this drug (71 active) | — | — | Malignant Skin Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03049189Phase 3 · active not recruiting Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01805271Phase 3 · active not recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01797523Phase 2 · completed A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma · 518 trials list this drug (71 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029001Phase 2 · recruiting Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment · 518 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03065387Phase 1 · terminated Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation · 518 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087554Phase 1 · active not recruiting Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217931Phase 2 · active not recruiting Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial · 518 trials list this drug (71 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 518 trials list this drug (71 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00640978Phase 2 · terminated Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer · 518 trials list this drug (71 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942734Phase 2 · completed Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087685Phase 2 · completed RAD001 in Recurrent Endometrial Cancer Patients · 518 trials list this drug (71 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113360Phase 2 · completed RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma · 518 trials list this drug (71 active) | — | — | Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00449748Phase 2 · completed Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis · 518 trials list this drug (71 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317720Phase 1/Phase 2 · completed Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032406Phase 2 · active not recruiting CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318324Phase 1 · recruiting Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06126588Phase 2 · recruiting Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial · 518 trials list this drug (71 active) | — | — | Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697408Phase 1/Phase 2 · active not recruiting Itacitinib + Everolimus in Hodgkin Lymphoma · 518 trials list this drug (71 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188548Phase 1 · active not recruiting A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05573126Phase 1/Phase 2 · recruiting Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081874Phase 1/Phase 2 · completed RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma · 518 trials list this drug (71 active) | — | — | Leukemia,Mantle Cell Lymphoma,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253318Phase 1 · terminated RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05306340Phase 3 · active not recruiting A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563220Phase 1/Phase 2 · active not recruiting Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07634601Phase 2 · not yet recruiting Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer · 518 trials list this drug (71 active) | — | — | Endometrial Carcinoma,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01412515Phase 2 · terminated A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma · 518 trials list this drug (71 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619950Phase 2 · not yet recruiting EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma · 518 trials list this drug (71 active) | — | — | Bone Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843253Phase 2 · recruiting Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant · 518 trials list this drug (71 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · 518 trials list this drug (71 active) | — | — | Endometrial Carcinoma,Endometrial Endometrioid Adenocarcinoma,Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114527Phase 2 · active not recruiting Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) · 518 trials list this drug (71 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02321501Phase 1 · active not recruiting Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer · 518 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195750Phase 3 · active not recruiting A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918302Phase 3 · recruiting Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. · 518 trials list this drug (71 active) | — | — | Thymus Neoplasm,Lung Neuroendocrine Neoplasm,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062965Phase 3 · recruiting A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068249Phase 2 · active not recruiting Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer · 518 trials list this drug (71 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165886Phase 2/Phase 3 · recruiting Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477576Phase 3 · recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy · 518 trials list this drug (71 active) | — | — | Digestive System Neuroendocrine Tumor,Neuroendocrine Tumor,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00819546Phase 1 · active not recruiting RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS · 518 trials list this drug (71 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477548Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies · 518 trials list this drug (71 active) | — | — | Nevus,Hemangioendothelioma,Hemangioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895748Phase 1 · terminated DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435584Phase 1/Phase 2 · not yet recruiting Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) · 518 trials list this drug (71 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811861Phase 3 · active not recruiting Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407517Phase 3 · not yet recruiting Adjuvant Intensification for LAR · 518 trials list this drug (71 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143726Phase 2 · active not recruiting Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer · 518 trials list this drug (71 active) | — | — | Thyroid Gland Oncocytic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674140Phase 3 · active not recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520063Phase 1/Phase 2 · completed Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407509Phase 1 · completed Phase I Trial of VS-6766 Alone and in Combination With Everolimus · 518 trials list this drug (71 active) | — | — | Solid Neoplasm,Malignant Lung Neoplasm,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02081755Phase 4 · enrolling by invitation Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer · 518 trials list this drug (71 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057133Phase 1 · active not recruiting A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024173Phase 3 · recruiting A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05933395Phase 2 · recruiting Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002177Phase 1/Phase 2 · recruiting A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC · 518 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00799188Phase 3 · completed CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial · 518 trials list this drug (71 active) | — | — | Malignant Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03284957Phase 1/Phase 2 · terminated Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185883Phase 1 · active not recruiting Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) · 518 trials list this drug (71 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120249Phase 3 · completed S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery · 518 trials list this drug (71 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919226Phase 3 · active not recruiting Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01734512Phase 2 · completed PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123823Phase 1 · completed BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834740early Phase 1 · completed A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection · 518 trials list this drug (71 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06994572Phase 1 · not yet recruiting Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma · 518 trials list this drug (71 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493152no longer available Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019) · 518 trials list this drug (71 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493165no longer available Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020) · 518 trials list this drug (71 active) | — | — | Uterine Corpus Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02246127Phase 3 · completed Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01313559Phase 2 · terminated Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer · 518 trials list this drug (71 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432518early Phase 1 · recruiting Pilot Trial for Treatment of Recurrent Glioblastoma · 518 trials list this drug (71 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03324373Phase 1 · completed Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339062Phase 1/Phase 2 · completed Cemiplimab in AlloSCT/SOT Recipients With CSCC · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173560Phase 2 · completed Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03659136Phase 2 · completed The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02531932Phase 2 · completed Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02991807Phase 1/Phase 2 · completed RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02842749Phase 4 · completed Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China · 518 trials list this drug (71 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839940Phase 3 · terminated Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02432560recruiting Safety and Durability of Sirolimus for Treatment of LAM · 518 trials list this drug (71 active) | — | — | Lymphangioleiomyomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06482086Phase 2 · recruiting Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer · 518 trials list this drug (71 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02216786Phase 2 · completed A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05293964Phase 1 · active not recruiting Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682611Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors. · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070301Phase 2 · completed A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594095Phase 2 · recruiting SNF Platform Study of HR+/ HER2-advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678664Phase 2 · completed Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00811590Phase 2 · terminated Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02228681Phase 2 · completed Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185831Phase 2 · unknown A MolEcularly Guided Anti-Cancer Drug Off-Label Trial · 518 trials list this drug (71 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · 518 trials list this drug (71 active) | — | — | Adult Solid Neoplasm,Melanoma,Cutaneous Merkel Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06561022Phase 2 · unknown Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833815Phase 2/Phase 3 · unknown Addition of Everolimus to Standard of Care in Carcinoma Gallbladder · 518 trials list this drug (71 active) | — | — | Malignant Gallbladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03154281Phase 1 · completed Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523977Phase 1 · completed Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL · 518 trials list this drug (71 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472388Phase 2 · recruiting Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor,Neuroendocrine Tumor G1,Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155920Phase 2 · completed Everolimus for Children With Recurrent or Progressive Ependymoma · 518 trials list this drug (71 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06301386Phase 2 · not yet recruiting Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients · 518 trials list this drug (71 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 518 trials list this drug (71 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345136Phase 2 · terminated Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma · 518 trials list this drug (71 active) | — | — | Vestibular Schwannoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02456857Phase 2 · completed Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative · 518 trials list this drug (71 active) | — | — | Invasive Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949541Phase 2 · recruiting Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03312738Phase 2 · completed A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05954442Phase 3 · unknown Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02332902Phase 2 · completed Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01215136Phase 2 · terminated First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma · 518 trials list this drug (71 active) | — | — | Transitional Cell Carcinoma,Urothelial Carcinoma,Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02258451Phase 2 · completed Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599324Phase 1/Phase 2 · completed Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors · 518 trials list this drug (71 active) | — | — | Urothelial Carcinoma,Colorectal Adenocarcinoma,Gastric Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264665completed OPALINE : A Study Of Morbidity And Mortality At 2 Years · 518 trials list this drug (71 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04591431Phase 2 · unknown The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Malignant Digestive System Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827384Phase 2 · completed MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations · 518 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00934895Phase 1/Phase 2 · terminated Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298713Phase 2 · completed Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03245151Phase 1/Phase 2 · completed Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02028364Phase 2 · completed Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983107Phase 2 · recruiting Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255788Phase 2 · completed Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387400Phase 1 · completed Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03328104Phase 1 · completed Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma · 518 trials list this drug (71 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · 518 trials list this drug (71 active) | — | — | Gastrin-Producing Neuroendocrine Tumor,Pancreatic Glucagonoma,Pancreatic Insulinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430572Phase 1 · completed Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02687958Phase 2 · unknown Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin · 518 trials list this drug (71 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106507Phase 1 · completed ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate · 518 trials list this drug (71 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333565Phase 2 · completed Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas · 518 trials list this drug (71 active) | — | — | Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01698918Phase 2 · completed Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · 518 trials list this drug (71 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05725200Phase 2 · recruiting Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer · 518 trials list this drug (71 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02915783Phase 2 · completed A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease · 518 trials list this drug (71 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355794Phase 1 · completed A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) · 518 trials list this drug (71 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Brain Stem Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890069Phase 1 · completed A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat · 518 trials list this drug (71 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642186Phase 2 · completed Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) · 518 trials list this drug (71 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023905Phase 2 · terminated Everolimus With and Without Temozolomide in Adult Low Grade Glioma · 518 trials list this drug (71 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00805129Phase 2 · completed Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium · 518 trials list this drug (71 active) | — | — | Transitional Cell Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830895Phase 2 · completed RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC) · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154439Phase 1 · completed Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 518 trials list this drug (71 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03352427Phase 2 · terminated Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations · 518 trials list this drug (71 active) | — | — | Glioma,Brain Stem Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03163667Phase 2 · completed CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) · 518 trials list this drug (71 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981162Phase 1 · completed Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride · 518 trials list this drug (71 active) | — | — | Adult Solid Neoplasm,Malignant Pancreatic Neoplasm,Pancreatic Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049047Phase 2 · completed Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy · 518 trials list this drug (71 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02871791Phase 1/Phase 2 · completed Palbociclib With Everolimus + Exemestane In BC · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02205515Phase 1/Phase 2 · completed An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis · 518 trials list this drug (71 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01582009Phase 1/Phase 2 · terminated Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate · 518 trials list this drug (71 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668784Phase 3 · completed Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229943Phase 2 · completed Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery · 518 trials list this drug (71 active) | — | — | Pancreatic Gastrinoma,Pancreatic Neuroendocrine Tumor,Pancreatic Vipoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04355858Phase 2 · unknown Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01034631Phase 1/Phase 2 · completed BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02120469Phase 1 · completed Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429684Phase 3 · unknown Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392821Phase 1/Phase 2 · completed Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer · 518 trials list this drug (71 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434602Phase 1/Phase 2 · completed Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas · 518 trials list this drug (71 active) | — | — | Glioblastoma,Brain Neoplasm,WHO Grade 3 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154335Phase 1 · completed Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer · 518 trials list this drug (71 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269670Phase 2 · terminated Phase II Study of Everolimus Beyond Progression · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03239015Phase 2 · unknown Efficacy and Safety of Precision Therapy in Refractory Tumor · 518 trials list this drug (71 active) | — | — | Neoplasm,Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01499160Phase 2 · terminated Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00886691Phase 2 · completed Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · 518 trials list this drug (71 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02236572Phase 2 · terminated Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01218555Phase 1 · completed Study of Everolimus (RAD001) in Combination With Lenalidomide · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05108740no longer available MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer · 518 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00805961Phase 2 · completed RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM · 518 trials list this drug (71 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00591734Phase 2 · completed RAD001 Plus Bevacizumab in Metastatic Melanoma · 518 trials list this drug (71 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724020Phase 2 · completed MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05124431Phase 2 · unknown Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00972335Phase 2 · terminated Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma · 518 trials list this drug (71 active) | — | — | Intracranial Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01263951Phase 2 · unknown Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01665768Phase 2 · completed Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma · 518 trials list this drug (71 active) | — | — | Hodgkin Lymphoma,Gray-Zone Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03139747Phase 2 · suspended UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone · 518 trials list this drug (71 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742051Phase 2 · completed A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03525834Phase 4 · completed Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. · 518 trials list this drug (71 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02451696Phase 2 · completed A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387020Phase 1 · completed Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors · 518 trials list this drug (71 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01524783Phase 3 · completed Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01931163Phase 2 · completed NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01784861Phase 1/Phase 2 · terminated VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors · 518 trials list this drug (71 active) | — | — | Adenocarcinoma,Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275222Phase 1/Phase 2 · completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors · 518 trials list this drug (71 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789281Phase 4 · completed Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. · 518 trials list this drug (71 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00702052Phase 2 · completed Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy · 518 trials list this drug (71 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02732119Phase 1/Phase 2 · completed Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. · 518 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125084Phase 1 · completed Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer · 518 trials list this drug (71 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860494Phase 2/Phase 3 · withdrawn Topical Everolimus in Patients With Tuberous Sclerosis Complex · 518 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01185366Phase 2 · terminated Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973204completed Circulating Tumor Cells and Tumor DNA in HCC and NET · 518 trials list this drug (71 active) | — | — | Neuroendocrine Tumor,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01865747Phase 3 · completed A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma · 518 trials list this drug (71 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |